Ireland Glucometer Market to Grow with a CAGR of 5.67% through 2028
The user-friendly design of miniaturized
glucometers are the major drivers for the Ireland Glucometer Market.
According
to TechSci Research report, “Ireland Glucometer Market –Industry Size,
Share, Trends, Competition, Opportunity and Forecast, 2018-2028”, the Ireland
Glucometer Market stood at USD 127.38 million in 2022 and is anticipated to
project robust growth in the forecast period with a CAGR of 5.67% through 2028.
This can be ascribed to initiatives by governmental bodies and organizations
that focus on diabetes prevention, education, and access to healthcare services
that have been launched to support individuals living with diabetes. These
efforts have contributed to a more supportive environment for diabetes
management, leading to increased demand for tools like glucometers.
In recent years, there has been a shift towards
self-monitoring for diabetes in Ireland. This shift has been driven by a number
of factors, including advances in technology and a growing recognition of the
importance of patient empowerment in managing chronic conditions like diabetes.
One of the key technologies driving this shift is glucose monitoring. New
technology for glucose monitoring is becoming more widely available in Ireland,
making it easier for people with diabetes to monitor their blood sugar levels.
Self-monitoring of blood glucose (SMBG) is considered useful for achieving and
maintaining near-normal blood glucose levels, providing feedback to the
healthcare provider and the patient. Structured self-monitoring of blood
glucose can be useful to help people understand the impact of food and activity
on their blood glucose levels.
Self-monitoring is particularly important for
people with type 2 diabetes, who may struggle to maintain healthy eating habits
and get enough exercise. Self-management interventions using a range of
approaches improve short-term glycemic control in people with type 2 diabetes.
There are a number of ways to monitor blood sugar levels, including
finger-prick tests and electronic blood sugar monitors like flash glucose
monitors or continuous glucose monitors (CGMs). More and more people with
diabetes are choosing to use a flash glucose monitor to check their sugar
levels. This is a blood sugar test without a needle, using a sensor worn on the
skin. Additionally,
Artificial intelligence is poised to revolutionize diabetes management.
Glucometers
equipped with AI algorithms can analyze blood glucose data in real-time,
offering actionable insights and predictive analysis. AI-powered glucometers
can anticipate potential glucose fluctuations and recommend personalized
interventions, empowering individuals with diabetes to make timely adjustments
to their lifestyle and treatment plans. This trend is expected to enhance
treatment outcomes and reduce the risk of complications. The ubiquity of
smartphones also has paved the way for glucometers to seamlessly integrate with
mobile applications.
This
integration allows users to sync their blood glucose data with smartphones,
enabling easy tracking, analysis, and data sharing with healthcare providers.
Mobile apps can provide actionable insights, medication reminders, and even
connect users with support networks. As mobile health (mHealth) technology
advances, the synergy between glucometers and smartphones is expected to play a
pivotal role in diabetes management. Additionally, Wearable technology has
integrated itself seamlessly into various aspects of our lives, from tracking
fitness to monitoring sleep patterns. Now, wearable glucometers are poised to
revolutionize diabetes management in Ireland.
These
devices, typically worn as patches, smartwatches, or other forms of discreet
wearables, offer a non-invasive and continuous monitoring solution for blood
glucose levels. Wearable glucometers eliminate the need for frequent finger
pricks, providing a more comfortable and less intrusive method of blood glucose
monitoring. This non-invasive approach is particularly beneficial for
individuals who may have a fear of needles or those who require frequent
glucose checks. Continuous monitoring enables real-time tracking of blood
glucose levels, offering individuals immediate insights into their glycemic
fluctuations. This real-time data empowers timely interventions, reducing the
risk of hyperglycemic or hypoglycemic episodes. Wearable glucometers seamlessly
integrate into daily routines, allowing individuals to monitor their glucose
levels while engaging in various activities. This integration supports a
holistic approach to diabetes management by considering the impact of lifestyle
choices on glycemic control.
However, regulatory hurdles and compliance and accuracy
and reliability are expected to slow down the growth of the market in the
coming years.
Browse
over XX market data Figures and spread through XX Pages and an in-depth TOC on
" Ireland Glucometer Market.”
The Ireland Glucometer Market segmentation is based
on Product Type, Technique, Type, Distribution Channel, End User, By Company, and
Region.
Some
of the major companies operating in the Ireland
Glucometer Market include:
- Abbott
Laboratories Ireland Ltd
- Roche
Ireland Ltd
- Medtronic
Ireland Ltd
- Bayer
Ltd/Ireland
- Ascensia
Diabetes Care Ireland
Download
Free Sample Report
Customers can also request for 10% free
customization on this report.
“Discreet glucometer monitoring is
revolutionizing diabetes management in Ireland by providing a private,
seamless, and user-friendly approach to tracking blood glucose levels. This
innovative practice respects individual privacy and dignity, allowing users to
monitor their glucose discreetly without drawing attention or causing social
discomfort. By integrating advanced technology, such as continuous glucose
monitoring (CGM), individuals can access real-time data to respond promptly to
fluctuations and prevent hyperglycemic or hypoglycemic episodes. The
convenience, comfort, and empowerment associated with discreet monitoring, is
expected to contribute to a remarkable growth of the Ireland Glucometer Market
in the forecast period," said Mr. Karan Chechi, Research Director with
TechSci Research, a research-based Global management consulting firm.
Ireland
Glucometer Market Segmented By Product Type (Self Glucose Monitoring
Glucometers, Continuous Glucose Monitoring Glucometers), By Technique
(Invasive, Non-Invasive), By Type (Wearable, Non-Wearable), By Distribution
Channel (Hospital Pharmacies, Retail Outlet, Online, Others), By End User
(Hospitals & Clinics, Diagnostic Centers, Home Care, Others), By Region, Competition,
Forecast and Opportunities, 2028
has evaluated the future growth potential of Ireland Glucometer Market and
provides statistics & information on market size, structure, and future
market growth. The report intends to provide innovative market intelligence and
help decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Ireland Glucometer Market.
Contact
Mr.
Ken Mathews
708
Third Avenue,
Manhattan,
NY,
New
York 10017
Tel:
+1-646-360-1656
Email: [email protected]
Website: www.techsciresearch.com